TABLE 1.
The baseline clinical characteristics of the breast cancer patients in this study.
| TCGA cohort |
GEO cohort |
P-value | |||
| GSE20685 | GSE20711 | GSE42568 | |||
| No. of patients | 1057 | 327 | 88 | 104 | / |
| Age (median, range) | 58 (26–90) | 46 (24–84) | / | 56 (31–90) | / |
| Stage (%) | |||||
| I | 181 | / | / | / | / |
| II | 598 | / | / | / | |
| III | 237 | / | / | / | |
| IV | 30 | / | / | / | |
| Unknown | 11 | / | / | / | |
| T | |||||
| 1 | 278 | 101 | / | / | 0.092 |
| 2 | 607 | 188 | / | / | |
| 3 | 132 | 26 | / | / | |
| 4 | 37 | 12 | / | / | |
| Unknown | 3 | 0 | / | / | |
| N | |||||
| 0 | 497 | 137 | / | / | <0.01 |
| 1 | 352 | 87 | / | / | |
| 2 | 119 | 63 | / | / | |
| 3 | 72 | 40 | / | / | |
| Unknown | 17 | 0 | / | / | |
| M | |||||
| 0 | 879 | 319 | / | / | 0.908 |
| 1 | 21 | 8 | / | / | |
| Unknown | 157 | 0 | / | / | |
| Survival status | |||||
| OS days (median) | 858 | 1862 | 2216 | 2197 | / |
The P-value represents the comparison of clinicopathological parameters of patients between the TCGA cohort and GSE20685.